1. Home
  2. RILYP vs VCEL Comparison

RILYP vs VCEL Comparison

Compare RILYP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B. Riley Financial Inc.

RILYP

B. Riley Financial Inc.

HOLD

Current Price

$7.73

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

SELL

Current Price

$39.81

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RILYP
VCEL
Founded
1973
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.1B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
RILYP
VCEL
Price
$7.73
$39.81
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $59.71
AVG Volume (30 Days)
10.9K
★ 511.9K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 7.03%
N/A
EPS Growth
★ 138.49
60.00
EPS
★ 6.47
N/A
Revenue
★ $967,599,000.00
$276,259,000.00
Revenue This Year
N/A
$21.71
Revenue Next Year
N/A
$16.86
P/E Ratio
$1.20
★ N/A
Revenue Growth
15.38
★ 16.45
52 Week Low
$3.25
$28.95
52 Week High
$17.52
$49.32

Technical Indicators

Market Signals
Indicator
RILYP
VCEL
Relative Strength Index (RSI) 17.39 48.55
Support Level N/A $37.78
Resistance Level $13.63 $41.21
Average True Range (ATR) 0.53 1.29
MACD -0.16 0.13
Stochastic Oscillator 9.12 47.50

Price Performance

Historical Comparison
RILYP
VCEL

About RILYP B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services, telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across various business lines. The Group has seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Capital Markets segment, which provides investment banking and institutional brokerage services, offers loans, trades in equity securities, and maintains an investment portfolio of public and private equities and debt securities. Geographically, the Group derives maximum revenue from its business in North America.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: